Ignite Creation Date:
2025-12-24 @ 11:51 PM
Ignite Modification Date:
2026-02-27 @ 11:20 AM
Study NCT ID:
NCT02452151
Status:
UNKNOWN
Last Update Posted:
2015-05-22
First Post:
2015-05-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
"Efficacy and Safety of Infliximab-biosimilar (Inflectra) Compared to Infliximab-innovator (Remicade) in Patients With Inflammatory Bowel Disease in Remission: the SIMILAR Trial"
Sponsor:
Onze Lieve Vrouwe Gasthuis
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
None
Primary Completion Date:
2016-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2016-09
Completion Date Type:
ESTIMATED
First Submit Date:
2015-05-20
First Submit QC Date:
None
Study First Post Date:
2015-05-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-05-21
Last Update Post Date:
2015-05-22
Last Update Post Date Type:
ESTIMATED